Morgana Mongraw-Chaffin1, Andrea Z LaCroix2, Dorothy D Sears3, Lorena Garcia4, Lawrence S Phillips5, Elena Salmoirago-Blotcher6, Oleg Zaslavsky7, Cheryl A M Anderson2. 1. Department of Medicine, University of California San Diego, San Diego, CA; Department of Epidemiology & Prevention, Wake Forest School of Medicine, Winston-Salem NC. Electronic address: mmongraw@wakehealth.edu. 2. Department of Family Medicine and Public Health, University of California San Diego, San Diego, CA. 3. Department of Medicine, University of California San Diego, San Diego, CA; Department of Family Medicine and Public Health, University of California San Diego, San Diego, CA. 4. Department of Public Health Services, University of California Davis, Davis, CA. 5. Atlanta VA Medical Center, Decatur, GA and Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA. 6. The Miriam Hospital Centers for Behavioral and Preventive Medicine at the Warren Alpert Medical School, Brown University, Providence, RI. 7. School of Nursing, University of Washington, Seattle, WA.
Abstract
BACKGROUND: While there is increasing recognition of the risks associated with hypoglycemia in patients with diabetes, few studies have investigated incident cause-specific cardiovascular outcomes with regard to low fasting glucose in the general population. OBJECTIVE: We hypothesized that low fasting glucose would be associated with cardiovascular disease risk and all-cause mortality in postmenopausal women. METHODS: To test our hypothesis, we used both continuous incidence rates and Cox proportional hazards models in 17,287 participants from the Women's Health Initiative with fasting glucose measured at baseline. Participants were separated into groups based on fasting glucose level: low (<80mg/dL), normal/reference (80-99mg/dL), impaired (100-125mg/dL), and diabetic (≥126mg/dL). RESULTS: Participants were free of cardiovascular disease at enrollment, had mean age of 62years, and were 52% Caucasian, 24% African American, 8% Asian, and 12% Hispanic. Median follow-up was 15years. Graphs of continuous incidence rates compared to fasting glucose distribution exhibited evidence of a weak J-shaped association with heart failure and mortality that was predominantly due to participants with treated diabetes. Impaired and diabetic fasting glucose were positively associated with all outcomes. Associations for low fasting glucose differed, with coronary heart disease (HR=0.64 (0.42, 0.98)) significantly inverse; stroke (0.73 (0.48, 1.13)), combined cardiovascular disease (0.91 (0.73, 1.14)), and all-cause mortality (0.97 (0.79, 1.20)) null or inverse and not significant; and heart failure (1.27 (0.80, 2.02)) positive and not significant. CONCLUSIONS: Fasting glucose at the upper range, but not the lower range, was significantly associated with incident cardiovascular disease and all-cause mortality.
BACKGROUND: While there is increasing recognition of the risks associated with hypoglycemia in patients with diabetes, few studies have investigated incident cause-specific cardiovascular outcomes with regard to low fasting glucose in the general population. OBJECTIVE: We hypothesized that low fasting glucose would be associated with cardiovascular disease risk and all-cause mortality in postmenopausal women. METHODS: To test our hypothesis, we used both continuous incidence rates and Cox proportional hazards models in 17,287 participants from the Women's Health Initiative with fasting glucose measured at baseline. Participants were separated into groups based on fasting glucose level: low (<80mg/dL), normal/reference (80-99mg/dL), impaired (100-125mg/dL), and diabetic (≥126mg/dL). RESULTS:Participants were free of cardiovascular disease at enrollment, had mean age of 62years, and were 52% Caucasian, 24% African American, 8% Asian, and 12% Hispanic. Median follow-up was 15years. Graphs of continuous incidence rates compared to fasting glucose distribution exhibited evidence of a weak J-shaped association with heart failure and mortality that was predominantly due to participants with treated diabetes. Impaired and diabetic fasting glucose were positively associated with all outcomes. Associations for low fasting glucose differed, with coronary heart disease (HR=0.64 (0.42, 0.98)) significantly inverse; stroke (0.73 (0.48, 1.13)), combined cardiovascular disease (0.91 (0.73, 1.14)), and all-cause mortality (0.97 (0.79, 1.20)) null or inverse and not significant; and heart failure (1.27 (0.80, 2.02)) positive and not significant. CONCLUSIONS: Fasting glucose at the upper range, but not the lower range, was significantly associated with incident cardiovascular disease and all-cause mortality.
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: David Preiss; Paul Welsh; Heather M Murray; James Shepherd; Chris Packard; Peter Macfarlane; Stuart Cobbe; Ian Ford; Naveed Sattar Journal: Eur Heart J Date: 2010-04-15 Impact factor: 29.983
Authors: Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati Journal: N Engl J Med Date: 2010-03-04 Impact factor: 91.245
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Michael E Miller; Jeff D Williamson; Hertzel C Gerstein; Robert P Byington; William C Cushman; Henry N Ginsberg; Walter T Ambrosius; Laura Lovato; William B Applegate Journal: Diabetes Care Date: 2013-10-29 Impact factor: 19.112
Authors: Chanshin Park; Eliseo Guallar; John A Linton; Duk-Chul Lee; Yangsoo Jang; Dong Koog Son; Eun-Jeong Han; Soo Jin Baek; Young Duk Yun; Sun Ha Jee; Jonathan M Samet Journal: Diabetes Care Date: 2013-02-12 Impact factor: 19.112
Authors: Jane Vermunt; Fiona Bragg; Jim Halsey; Ling Yang; Yiping Chen; Yu Guo; Huaidong Du; Fanwen Meng; Pei Pei; Canqing Yu; Jun Lv; Junshi Chen; Liming Li; Sarah Lewington; Zhengming Chen Journal: BMJ Open Diabetes Res Care Date: 2021-11